| Cvs Pharmacy #01132 | |
| 13 1/2 Pond Street, Newburyport, Massachusetts 01950 | |
| (978) 462-6539 |
| Name | Cvs Pharmacy #01132 |
|---|---|
| Organization Name | Cvs Pharmacy Inc |
| Location | 13 1/2 Pond Street, Newburyport, Massachusetts 01950 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (978) 462-6539 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The quality of general family functioning is a major determinant of healthy dietary habits - according to new research published in the Journal of Caries Research and led by Queen Mary University of London.
The first genetic test for Psoriatic arthritis (PsA) is being launched today by PsoriasisDX, LLC, a subsidiary of molecular dermatology research and development innovator PharmaGenoma, Inc. PsA is a progressive irreversible joint disease associated with psoriasis. It is estimated that 20% to 40% of psoriasis patients will eventually develop PsA.
OB Complete Gold is a breakthrough innovation in prenatal vitamin supplements that contains the advanced technology OmEGGa DHA, providing a novel egg-based DHA that comes from cage-free hens.
Pfizer Inc. today announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of attention deficit hyperactivity disorder (ADHD).
TNF inhibitors indicated for the treatment of rheumatoid arthritis, psoriasis and inflammatory bowel disease formed the largest share of the market, according to a new report available on companiesandmarkets.com. The top three products: Remicade, Humira and Enbrel accounted for 40.1% of the market in 2010.
› Verified 6 days ago
| NPI Number | 1588763940 |
| Organization Name | CVS PHARMACY INC |
| Doing Business As | CVS PHARMACY #01132 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 13 1/2 Pond St, Newburyport, MA 01950 |
| Phone Number | 508-462-5339 |
News Archive
The quality of general family functioning is a major determinant of healthy dietary habits - according to new research published in the Journal of Caries Research and led by Queen Mary University of London.
The first genetic test for Psoriatic arthritis (PsA) is being launched today by PsoriasisDX, LLC, a subsidiary of molecular dermatology research and development innovator PharmaGenoma, Inc. PsA is a progressive irreversible joint disease associated with psoriasis. It is estimated that 20% to 40% of psoriasis patients will eventually develop PsA.
OB Complete Gold is a breakthrough innovation in prenatal vitamin supplements that contains the advanced technology OmEGGa DHA, providing a novel egg-based DHA that comes from cage-free hens.
Pfizer Inc. today announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of attention deficit hyperactivity disorder (ADHD).
TNF inhibitors indicated for the treatment of rheumatoid arthritis, psoriasis and inflammatory bowel disease formed the largest share of the market, according to a new report available on companiesandmarkets.com. The top three products: Remicade, Humira and Enbrel accounted for 40.1% of the market in 2010.
› Verified 6 days ago
News Archive
The quality of general family functioning is a major determinant of healthy dietary habits - according to new research published in the Journal of Caries Research and led by Queen Mary University of London.
The first genetic test for Psoriatic arthritis (PsA) is being launched today by PsoriasisDX, LLC, a subsidiary of molecular dermatology research and development innovator PharmaGenoma, Inc. PsA is a progressive irreversible joint disease associated with psoriasis. It is estimated that 20% to 40% of psoriasis patients will eventually develop PsA.
OB Complete Gold is a breakthrough innovation in prenatal vitamin supplements that contains the advanced technology OmEGGa DHA, providing a novel egg-based DHA that comes from cage-free hens.
Pfizer Inc. today announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of attention deficit hyperactivity disorder (ADHD).
TNF inhibitors indicated for the treatment of rheumatoid arthritis, psoriasis and inflammatory bowel disease formed the largest share of the market, according to a new report available on companiesandmarkets.com. The top three products: Remicade, Humira and Enbrel accounted for 40.1% of the market in 2010.
› Verified 6 days ago
Cvs Pharmacy #01132 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 13 1/2 Pond Street, Newburyport, Massachusetts 01950 Phone: (978) 462-6539 | |
Cvs Pharmacy #10502 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 75 Storey Ave, Newburyport, Massachusetts 01950 Phone: (978) 462-1201 | |
Walgreens #2564 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 25 Storey Ave, Newburyport, Massachusetts 01950 Phone: (978) 462-0709 | |
Watts Eye Associates Llc Type: Medicare Supplier Location: 33 Low St, Newburyport, Massachusetts 01950 Phone: (978) 462-2020 |